<p>Mice were immunized i.n. or s.l. with 3M2eC (10 ug) plus CT (2 ug) on days 0 and 14 and challenged by i.n. administration of A/CA/04/09 (H1N1) 5 weeks after the last immunization. (A) Virus titers in the lung tissue at day 5 after challenge were determined in embryonated chicken eggs. (B) Body weight was monitored daily after the viral challenge. The results are expressed as the means+S.D. for the group. Significant differences were expressed as *, <i>P</i><0.05.</p
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>SCID mice were challenged with 10<sup>5</sup> TCID<sub>50</sub> pandemic H1N1 (H1N1 A/California/...
<p>Four groups of mice were infected with a non-lethal dose of influenza (0.33×MLD<sub>50</sub>) as ...
<p>Mice were challenged one month after vaccination (0.5 µg PZQ/0.1 µg antigen). (A) Viral loads in ...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Groups of CD1 mice were immunized twice with five-fold serial dilutions of pandemic H1N1 (H1N1 A/...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Six-week-old female BALB/c mice (n = 6) were immunized twice with 10 ug of 3M2eC protein plus 2 u...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>Nine week old, C57B/6 mice were passively immunized with a total 150 µg of indicated monoclonal a...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>Mouse groups were immunized with H1HA, H5b+H7H9b+H1HA, or ΔE1E3 twice at four week intervals. Fou...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>SCID mice were challenged with 10<sup>5</sup> TCID<sub>50</sub> pandemic H1N1 (H1N1 A/California/...
<p>Four groups of mice were infected with a non-lethal dose of influenza (0.33×MLD<sub>50</sub>) as ...
<p>Mice were challenged one month after vaccination (0.5 µg PZQ/0.1 µg antigen). (A) Viral loads in ...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>Balb/c mice were immunized according to <a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Groups of CD1 mice were immunized twice with five-fold serial dilutions of pandemic H1N1 (H1N1 A/...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>Six-week-old female BALB/c mice (n = 6) were immunized twice with 10 ug of 3M2eC protein plus 2 u...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>Nine week old, C57B/6 mice were passively immunized with a total 150 µg of indicated monoclonal a...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>Mouse groups were immunized with H1HA, H5b+H7H9b+H1HA, or ΔE1E3 twice at four week intervals. Fou...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>SCID mice were challenged with 10<sup>5</sup> TCID<sub>50</sub> pandemic H1N1 (H1N1 A/California/...
<p>Four groups of mice were infected with a non-lethal dose of influenza (0.33×MLD<sub>50</sub>) as ...